Skip to main content

InflaRx N.V.

IFRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001708688

No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding InflaRx N.V. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of IFRX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders2734+7
Shares18.6M19.4M+811.6K (+4.4%)
Value$24.9M$19.6M−$5.30M (−21.3%)

New holders (13)

Institutions that held InflaRx N.V. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IFRX in Q4 2025
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP406,315$410.4K0.00%
T3 Companies, LLC291,014$293.9K0.38%
DCF Advisers, LLC158,500$160.1K0.05%
XTX Topco Ltd133,760$135.1K0.00%
Quadrature Capital Ltd103,337$104.4K0.00%
Insigneo Advisory Services, LLC60,250$60.9K0.00%
HRT Financial LP47,486$47.0K0.00%
Two Sigma Securities, LLC11,165$11.3K0.00%
Steward Partners Investment Advisory, LLC10,000$10.1K0.00%
Integrated Wealth Concepts LLC10,000$10.1K0.00%
Chung Wu Investment Group, LLC9,000$9.09K0.01%
Jones Financial Companies LLLP1,784$1.80K0.00%
Keating Financial Advisory Services, Inc.671$6780.00%

Sold out (6)

Institutions that held InflaRx N.V. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of IFRX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Ra Capital Management, L.P.1,973,233$2.64M
Ikarian Capital, LLC722,066$967.6K
Adage Capital Partners GP, L.L.C.331,113$443.7K
Boothbay Fund Management, LLC175,114$234.7K
ADAR1 Capital Management, LLC159,479$213.7K
Birchview Capital, LP50,000$67.0K